Olr694 inhibitors represent a class of chemical compounds that specifically target and modulate the function of the Olr694 receptor. This receptor, encoded by the Olr694 gene, is part of the extensive family of olfactory receptors which are responsible for detecting odor molecules in the environment. Olfactory receptors, including Olr694, are G protein-coupled receptors (GPCRs) that reside in the cell membranes of olfactory sensory neurons. When an odorant binds to an olfactory receptor like Olr694, it initiates a cascade of intracellular signaling that ultimately leads to the perception of smell. Inhibitors of Olr694 interfere with this binding process, preventing the receptor from activating the downstream signaling pathways. These inhibitors are crucial tools for scientists aiming to understand the specific roles and mechanisms of individual olfactory receptors in the broader context of olfactory signal transduction.
Structurally, Olr694 inhibitors can vary widely but often share common pharmacophoric elements that allow them to bind with high specificity to the receptor's active site. The chemical design of these inhibitors typically involves the identification and optimization of binding affinities through methods such as high-throughput screening and structure-activity relationship (SAR) studies. Advanced techniques like X-ray crystallography and molecular docking are frequently employed to elucidate the precise interaction modes between the inhibitors and the Olr694 receptor. These insights facilitate the rational design of more potent and selective inhibitors. Understanding the structural and functional nuances of Olr694 and its inhibitors not only enhances our knowledge of olfactory biology but also provides a broader framework for studying GPCR modulation. The research into these inhibitors continues to be a vibrant field, offering significant contributions to the fundamental science of sensory perception and receptor-ligand interactions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Homoharringtonine | 26833-87-4 | sc-202652 sc-202652A sc-202652B | 1 mg 5 mg 10 mg | $52.00 $125.00 $182.00 | 11 | |
Inhibits protein synthesis, potentially affecting proteins involved in cell cycle and apoptosis. | ||||||
Fludarabine | 21679-14-1 | sc-204755 sc-204755A | 5 mg 25 mg | $58.00 $204.00 | 15 | |
Purine analog, potentially disrupting DNA synthesis and affecting cell replication proteins. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
DNA methyltransferase inhibitor, potentially altering gene expression and protein function. | ||||||
5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine | 1032900-25-6 | sc-505041 | 1 mg | $230.00 | ||
ALK inhibitor, potentially disrupting proteins in ALK-driven signaling pathways. | ||||||
Abemaciclib | 1231929-97-7 | sc-507342 | 10 mg | $110.00 | ||
Inhibits cyclin-dependent kinases 4 and 6, potentially affecting cell cycle-related proteins. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
HDAC inhibitor, potentially impacting gene expression and chromatin remodeling proteins. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
JAK1/2 inhibitor, potentially influencing proteins in cytokine signaling pathways. | ||||||
EPZ6438 | 1403254-99-8 | sc-507456 | 1 mg | $66.00 | ||
EZH2 inhibitor, potentially affecting proteins involved in histone methylation and gene expression. | ||||||
Entrectinib | 1108743-60-7 | sc-507438 | 5 mg | $180.00 | ||
TRK inhibitor, potentially affecting proteins in neurotrophic receptor tyrosine kinase signaling pathways. | ||||||